Stemtech Corporation (STEK)

OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
At close: Mar 6, 2026
-99.20%
Market Cap 337.07K
Revenue (ttm) 3.73M
Net Income (ttm) -2.96M
Shares Out 1.12B
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,871,196
Average Volume 16,538,784
Open 0.0003
Previous Close 0.0003
Day's Range 0.0003 - 0.0003
52-Week Range 0.0002 - 0.0420
Beta 2.31
RSI 39.91
Earnings Date May 11, 2026

About Stemtech

Stemtech Corporation, a stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia. The company’s products enhance and support the work of the body’s stem cells by releasing more stem cells, helping to circulate them in the blood, and migrate them into tissues, where they can perform their daily function of renewal for optimal health. It offers rapid renew stem cell peptide night cream under the RCM System, stemrelease3, Stemflo MigraStem, OraStem,... [Read more]

Sector Healthcare
Founded 2005
Employees 80
Stock Exchange OTCMKTS
Ticker Symbol STEK
Full Company Profile

Financial Performance

In 2024, Stemtech's revenue was $5.05 million, an increase of 2.69% compared to the previous year's $4.92 million. Losses were -$3.77 million, -30.58% less than in 2023.

Financial Statements

News

There is no news available yet.